Cardiovascular diseases, respiratory diseases and cancer were assessed at baseline and for up to 180 days. The main biomarker studied was NNAL – 4-(methylnitrosamino)-1-(3-pyridyll)-1-butanol, showing the effects of nicotine-derived nitrosamine ketone (associated with lung...